[go: up one dir, main page]

PE20160603A1 - Marcadores de riesgo para cardiovasculopatias en pacientes con nefropatia cronica - Google Patents

Marcadores de riesgo para cardiovasculopatias en pacientes con nefropatia cronica

Info

Publication number
PE20160603A1
PE20160603A1 PE2016000302A PE2016000302A PE20160603A1 PE 20160603 A1 PE20160603 A1 PE 20160603A1 PE 2016000302 A PE2016000302 A PE 2016000302A PE 2016000302 A PE2016000302 A PE 2016000302A PE 20160603 A1 PE20160603 A1 PE 20160603A1
Authority
PE
Peru
Prior art keywords
chronic
risk
nephropatia
cardiovasculopathies
patients
Prior art date
Application number
PE2016000302A
Other languages
English (en)
Inventor
Manuel Arias
Roberto Elosua
Sara Pich
Sergio Castillo
Eduardo Salas
Original Assignee
Gendiag Exe Sl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49054458&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20160603(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gendiag Exe Sl filed Critical Gendiag Exe Sl
Publication of PE20160603A1 publication Critical patent/PE20160603A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La invencion se refiere a un metodo para determinar el riesgo que presenta un sujeto que padece una nefropatia cronica de sufrir una cardiovasculopatia, sobre la base de la presencia de diferentes polimorfismos, asi como tambien se refiere a kits para practicar los metodos anteriores. La invencion tambien se refiere a un metodo para determinar el riesgo de padecer una cardiovasculopatia al combinar la ausencia o la presencia de uno o mas marcadores polimorficos en una muestra obtenida de un sujeto con factores de riesgo clinicos/bioquimicos para la evo, ademas de los medios de implementacion informatica para llevar a cabo dicho metodo
PE2016000302A 2013-08-30 2014-08-29 Marcadores de riesgo para cardiovasculopatias en pacientes con nefropatia cronica PE20160603A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP13182484.9A EP2843056B8 (en) 2013-08-30 2013-08-30 Risk markers for cardiovascular disease in patients with chronic kidney disease

Publications (1)

Publication Number Publication Date
PE20160603A1 true PE20160603A1 (es) 2016-07-03

Family

ID=49054458

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2016000302A PE20160603A1 (es) 2013-08-30 2014-08-29 Marcadores de riesgo para cardiovasculopatias en pacientes con nefropatia cronica

Country Status (13)

Country Link
US (1) US20160215341A1 (es)
EP (2) EP2843056B8 (es)
JP (1) JP2016528907A (es)
AR (1) AR097489A1 (es)
AU (1) AU2014314097A1 (es)
CA (1) CA2922329A1 (es)
CL (1) CL2016000447A1 (es)
MX (1) MX2016002529A (es)
PE (1) PE20160603A1 (es)
RU (1) RU2656148C2 (es)
SG (1) SG11201601490XA (es)
UY (1) UY35719A (es)
WO (1) WO2015028612A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108172296A (zh) * 2018-01-23 2018-06-15 上海其明信息技术有限公司 一种数据库的建立方法和遗传疾病的风险预测方法
CN108897985A (zh) * 2018-05-04 2018-11-27 上海市内分泌代谢病研究所 一种糖化血红蛋白HbA1c遗传位点评分的方法及其应用
CN111354464B (zh) * 2018-12-24 2024-05-17 深圳先进技术研究院 Cad预测模型建立方法、装置以及电子设备
RU2709837C1 (ru) * 2019-03-29 2019-12-23 федеральное государственное автономное образовательное учреждение высшего образования Первый Московский государственный медицинский университет имени И.М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский университет) (ФГАОУ ВО Первый МГМУ им. И.М. Сеченова Минздрава России (Се Способ прогнозирования вероятности интраоперационных и ранних послеоперационных осложнений при органосохраняющих операциях при опухолях паренхимы почек
CN112034189B (zh) * 2020-06-16 2023-03-17 广东省中医院（广州中医药大学第二附属医院、广州中医药大学第二临床医学院、广东省中医药科学院） 内皮素-1作为用于评价原发性慢性肾脏病患者无症状心血管器官损伤的标志物的应用
CN113643753B (zh) * 2021-05-26 2022-07-26 中国医学科学院阜外医院 冠心病多基因遗传风险评分及联合临床风险评估应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4883750A (en) 1984-12-13 1989-11-28 Applied Biosystems, Inc. Detection of specific sequences in nucleic acids
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
US6159693A (en) 1998-03-13 2000-12-12 Promega Corporation Nucleic acid detection
WO2008060618A2 (en) * 2006-11-15 2008-05-22 University Of Florida Research Foundation Use of genetic determinants in cardiovascular risk assessment
WO2009117122A2 (en) * 2008-03-19 2009-09-24 Existence Genetics Llc Genetic analysis
PT2264183T (pt) * 2009-06-09 2017-03-14 Gendiag Exe Sl Marcadores de risco para doença cardiovascular
ES2387292B1 (es) * 2010-06-29 2013-10-30 Fundacio Institut De Recerca Hospital Universitari Vall D'hebron Combinacion de snps para determinar el riesgo de sufrir una enfermedad neurovascular
ES2573648T3 (es) * 2011-08-05 2016-06-09 Gendiag.Exe, S.L. Marcadores genéticos para la evaluación del riesgo de enfermedad cardiovascular
WO2013080227A1 (en) * 2011-11-28 2013-06-06 Decode Genetics Ehf Genetic variants useful for risk assessment of arterial disease

Also Published As

Publication number Publication date
RU2016111308A (ru) 2017-10-05
AR097489A1 (es) 2016-03-16
EP2843056B8 (en) 2019-06-26
CL2016000447A1 (es) 2016-12-09
UY35719A (es) 2015-01-30
MX2016002529A (es) 2016-06-21
EP2843056B1 (en) 2019-04-10
EP3039156A1 (en) 2016-07-06
WO2015028612A1 (en) 2015-03-05
JP2016528907A (ja) 2016-09-23
AU2014314097A1 (en) 2016-03-24
CA2922329A1 (en) 2015-03-05
US20160215341A1 (en) 2016-07-28
RU2656148C2 (ru) 2018-05-31
EP2843056A1 (en) 2015-03-04
SG11201601490XA (en) 2016-03-30
EP3039156B1 (en) 2019-01-02

Similar Documents

Publication Publication Date Title
AR077026A1 (es) Marcadores de riesgo para enfermedades cardiovasculares
PE20160603A1 (es) Marcadores de riesgo para cardiovasculopatias en pacientes con nefropatia cronica
DOP2013000296A (es) Enfermedad tromboembólica
EA201590027A1 (ru) Способы детекции заболеваний или состояний
MX2013014153A (es) Biomarcadores paa terapia de inhibidor de hedgehog.
DK2890717T3 (da) Diagnostiske assays og kits til detektering af folatreceptor 1
MX2017008421A (es) Métodos terapéuticos, diagnósticos y pronósticos para el cáncer de vejiga.
MX387719B (es) Biomarcadores de la enfermedad del hígado graso no alcohólico (nafld) y la esteatohepatitis no alcohólica (nash) y usos de estos.
CR20140229A (es) Nuevos derivados bicíclicos de dihidroisoquinolin-1-ona
BR112016030798A8 (pt) composição de marcação fluorescente, métodos para determinar se um local foi limpo e para avaliar a limpeza de uma superfície, e, kits para determinar se uma superfície foi limpa e para avaliar a limpeza de uma superfície
BR112014027465A2 (pt) teste de imunosseleção de multiplex.
UY34165A (es) ?compuestos aldh-2 mitocondriales humanos para el tratamiento de la adicción?.
HUE046976T2 (hu) Sürgõsségi ülésszakok létesítési okainak meghatározása
DK2732260T3 (da) Prøveopsamlingskit
EA201591742A1 (ru) Способ улучшения диагностики заболеваний с использованием измеряемых аналитов
EP2333529A4 (en) FLUORESCENT X-RAY ANALYSIS METHOD
CL2017001212A1 (es) Composiciones, dispositivos y método para pruebas de sensibilidad de síndrome del intestino irritable
UY34097A (es) Alineación de anticoagulante de cebado para extracción de sangre.
MX2016001719A (es) Metodos y equipos para predecir el riesgo de tener una enfermedad o evento cardiovascular.
RU2011116763A (ru) Способ количественного определения термического стресса, которому подвергался фруктовый сок
MX2014006187A (es) Composiciones y metodos para el analisis de cancer de prostata.
CR20130688A (es) Método, compuestos y dispositivo para preparar espécimenes citológicos
BR112014024458A2 (pt) método para identificar uma composição líquida.
EP2856254A4 (en) BLADE ASSEMBLY FOR A LUMINESCENT BASED SAMPLE ANALYSIS DEVICE
ES2414290R1 (es) Metodo para el diagnostico y/o pronostico de dano renal agudo

Legal Events

Date Code Title Description
FD Application declared void or lapsed